Peripheral arterial disease

Diabetologia Croatica

Volumn 39, Issue 2, 2010, Pages 67-77

  Boras, Jozo ^a   Brkljačić, Neva ^a   Ljubičić, Antonela ^a   Ljubić, Spomenka ^a  

^a University of Zagreb   (Croatia)

Author keywords

Atherosclerosis; Diabetes mellitus; Intermittent claudication; Noninvasive diagnostic tests; Peripheral arterial disease; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; PENTOXIFYLLINE; PLACEBO; TICLOPIDINE;

ANKLE BRACHIAL INDEX; ANTICOAGULATION; AORTOFEMORAL BYPASS; BLEEDING TIME; CLAUDICATION; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; FEMOROPOPLITEAL BYPASS; FEMOROPOPLITEAL OCCLUSIVE DISEASE; HEART INFARCTION; HUMAN; INFRAINGUINAL OCCLUSIVE DISEASE; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; LEG AMPUTATION; LEG PAIN; LEG REVASCULARIZATION; LERICHE SYNDROME; LIFESTYLE MODIFICATION; LIMB ISCHEMIA; LIMB SALVAGE; NON INVASIVE MEASUREMENT; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIMARY PREVENTION; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; THROMBOCYTE AGGREGATION; TREADMILL EXERCISE; TREATMENT INDICATION; VASCULAR SURGERY; WALKING SPEED;

EID: 77958029999     PISSN: 03510042     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Murabito JM, D'Agostino RB, Silbershatz H, et al. Intermittent claudication. A risk profile from the Framingham Study. Circulation 1997;96:44-49.
2. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-743.
3. Jude EB, Oyibo SO, Chalmer N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001;24:1433-1437.
4. Aboyans V, Criqui MH, Denenberg JO, et al. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006;113:2623-2629.
5. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/ Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society for Interventional Radiology, and ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease): endorced by American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-654.
6. Norgren L, Hiatt WR, Dormandy JA, et al. Inter- Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.
7. McDermott MM, Greenland P, Li K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001;286:1599-1606.
8. Hirsch AT, Criqiu MH, Treat-Jacobson D, et al. Peripheral arterial disease detection awareness, and treatment in primary care. JAMA 2001:286:1317-1324.
9. Rimmer JM, Gennari FJ. Atherosclerosis renovascular disease and progressive renal failure. Ann Intern Med 1993;118:712-719.
10. McDermott MM, Kerwin DR, Liu K, et al. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med 2001;16:384- 390.
11. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004;292:453-461.
12. Olin JW, Kaufman JA, Bluemke DA, et al. Atherosclerotic vascular disease conference: Writing Group IV: Imaging. Circulation 2004;109:2626-2633.
13. Belch JJ, Topol EJ, Agnelli G, Bertrand M. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003;163:884-892.
14. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-1621.
15. McPhail IR, Spittell PC, Weston SA, Bailey KR. Intermittent claudication: an objective office-based assessment. J Am Coll Cardiol 2001;37:1381-5.
16. Kuller LH, Shemanski L, Psaty BM, et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation 1995;92:720-726.
17. Vogt MT, Cauley JA, Newman AB, et al. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 1993;270:465- 469.
18. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004;109:733- 739.
19. Murabito JM, Evans JC, Larson MG, et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med 2003;163:1939-1942.
20. O'Hare AM, Rodriguez RA, Bacchetti P. Low ankle-brachial index associated with rise in creatinine level over time: results from the Atherosclerosis Risk in Communities Study. Arch Intern Med 2005;165:1481-1485.
21. Heintz SE, Bone GE, Slaymaker EE, et al. Value of arterial pressure measurements in the proximal and distal part of the thigh in arterial occlusive disease. Surg Gynecol Obstet 1978;146:337-343.
22. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholestorol in adults (Adult Treatment Panel III). Circulation 2002;106:3143-3421.
23. Meijer WT, Grobbee DE, Hunink MG, et al. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med 2000;160:2934-2938.
24. Sobel M, Verhaeghe R. Antithrombotic therapy for peripheral artery occlusive disease; American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133:815S-843S.
25. Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (PROPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008;337:a1840.
26. Goldhaber SZ, Manson JE, Stampfer MJ, et al. Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians Health Study. Lancet 1992;340:143-145.
27. Libretti A, Catalano M. Treatment of claudication with dipyridamole and aspirin. Int J Clin Pharmacol Res 1986;6:59-60.
28. Westendorp IC, Veld BA, Grobbe DE, et al. Hormone replacement therapy and peripheral arterial disease: the Rotterdam study. Arch Intern Med 2000;160:2498-2502.
29. Hsia J, Simon JA, Lin F, et al. Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement study. Circulation 2000;102:2228-2232.
30. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-1339.
31. Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol 2002;90:1314-1319.
32. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 2000;109:523-530.
33. Ouriel K. Peripheral arterial disease. Lancet 2001;358:1257-1264.
34. Wolf GL, Wilson SE, Cross AP, et al. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. J Vasc Interv Radiol 1993;4:639-648.
35. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischemia or the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934.
36. Currie IC, Wilson YG, Baird RN, et al. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995;10:356- 361.
37. Poulias GE, Doundoulakis N, Prombonas E, et al. Aorto-femoral bypass and determinants of early success and late favourable outcome. Experience with 1000 consecutive cases. J Cardiovasc Surg 1992;33:664-678.
38. DeBakey ME, Glaeser DH. Patterns of atherosclerosis: effect of risk factors on recurrence and survival - analysis of 11890 cases with more than 25-year follow-up. Am J Cardiol 2000;85:1045-1053.